Glenmark subsidiary IPO to open next week
New Delhi: Glenmark Pharmaceuticals on Tuesday said the initial public offering of its subsidiary Glenmark Life Sciences will open on July 27.On July 19, Glenmark Life Sciences had filed the red herring prospectus for the offer with the Registrar of Companies, Pune and it was taken on record by the ROC the next day, Glenmark Pharma said in a BSE filing.The proposed offer will have fresh...
New Delhi: Glenmark Pharmaceuticals on Tuesday said the initial public offering of its subsidiary Glenmark Life Sciences will open on July 27.
On July 19, Glenmark Life Sciences had filed the red herring prospectus for the offer with the Registrar of Companies, Pune and it was taken on record by the ROC the next day, Glenmark Pharma said in a BSE filing.
The proposed offer will have fresh issue worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma, it added.
Read also: Glenmark to conduct phase 3 trials of nasal spray it claims to be effective in COVID treatment
The offer will open on July 27, 2021 and close on July 29, the filing said.
The expected date of listing is August 6, 2021.
Read also: Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd